Stay updated on TQ05105 Tablets in Refractory aGVHD Clinical Trial
Sign up to get notified when there's something new on the TQ05105 Tablets in Refractory aGVHD Clinical Trial page.

Latest updates to the TQ05105 Tablets in Refractory aGVHD Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedA new revision entry, v3.6.3, was added to the study's history, replacing the previous v3.6.2 entry as part of ongoing record updates. This appears to be administrative maintenance rather than changes to the study design or eligibility.SummaryDifference0.1%

- Check23 days agoChange DetectedAn updated revision entry v3.6.2 has been added to the study record history, and the older entry v3.6.0 has been removed. This reflects an administrative update to the study record's version history rather than changes to the study content or results.SummaryDifference0.1%

- Check38 days agoChange DetectedThe record history shows a new recruitment status indicating enrollment is closed, and adds a new version tag 'Revision: v3.6.0' while removing the earlier 'Revision: v3.5.5' entry.SummaryDifference0.6%

- Check45 days agoChange DetectedThe history adds that the study was closed and terminated for business reasons, with a note that safety and efficacy concerns did not drive the closure. A new revision (v3.5.5) is posted and the previous 'Completed' status was removed.SummaryDifference0.9%

- Check66 days agoChange DetectedFooter now shows Revision: v3.5.4 instead of v3.5.3, reflecting a new release version of the record history page. This update appears to be a metadata update rather than a modification to the study information.SummaryDifference0.1%

- Check81 days agoChange DetectedA new revision v3.5.3 was added to the study's record history, indicating an update to the trial record. The previous revision v3.5.2 was removed from the history view.SummaryDifference0.1%

Stay in the know with updates to TQ05105 Tablets in Refractory aGVHD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TQ05105 Tablets in Refractory aGVHD Clinical Trial page.